Open AccessStudy Shows Immunologic Doublet Active Among Relapsed Patients
Author(s) -
Catlin Nalley
Publication year - 2017
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000527122.83497.ae
Subject(s) - obinutuzumab , follicular lymphoma , lenalidomide , medicine , oncology , lymphoma , regimen , rituximab , follicular phase , chemotherapy , salvage therapy , multiple myeloma